Abacus FCF Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $427K | Buy |
11,798
+1,728
| +17% | +$62.5K | 1.33% | 2 |
|
|
2017
Q2 | $260K | Buy |
10,070
+5,157
| +105% | +$133K | 1.01% | 40 |
|
|
2017
Q1 | $94K | Buy |
4,913
+2,312
| +89% | +$44.2K | 0.78% | 95 |
|
|
2016
Q4 | $43K | Buy |
2,601
+1,461
| +128% | +$24.2K | 0.72% | 100 |
|
|
2016
Q3 | $23K | Buy |
+1,140
| New | +$23K | 0.92% | 99 |
|